Pharmafocus Home
    
Keyword Search
Go News Archive Features Events Appointments Jobs Contact Us About Us
Latest Features ( May )
Should I stay or should I go?
There are no easy answers when it comes to timing a job move, says Tim Ewbank, but you can make yourself a more attractive candidate for that next job.(more)
Regional research still hampered by cross-border differences
In the age of the Euro-trial, patients are not well served by processes that add unnecessary delays to the development of new medicines, says Les Rose(more)
A sea of paperwork or business as usual?
Steven Gray looks ahead to the soon-to-be finalised 2008 ABPI Code of Practice and how it will affect everyday practice in the UK industry(more)
PharmafocusNews Register for New Alert
News for October 2007
Previous Months: April 2008 |  March 2008 |  February 2008 |  January 2008 |  December 2007 |  November 2007 |  October 2007 |  September 2007 |  August 2007 |  July 2007 |  June 2007 |  May 2007 |  April 2007 |  March 2007 |  February 2007 |  January 2007 |  December 2006 |  November 2006 |  October 2006 |  September 2006 |  August 2006 |  July 2006 |  June 2006 |  May 2006 |  April 2006 |  March 2006 |  February 2006 |  January 2006 |  December 2005 |  November 2005 |  October 2005 |  September 2005 |  August 2005 |  July 2005 |  June 2005 |  May 2005 |  April 2005 |  March 2005 |  February 2005 |  January 2005 |  December 2004 |  November 2004 |  October 2004 |  September 2004 |  August 2004 |  July 2004 |  June 2004 |  May 2004 |  April 2004 |  March 2004 |  February 2004 |  January 2004 |  December 2003 |  November 2003 |  October 2003 |  September 2003 |  August 2003 |  July 2003 |  June 2003 |  May 2003 |  April 2003 |  March 2003 |  February 2003 |  January 2003 |  December 2002 |  November 2002 | 

  What is RSS?

Biotech firms call for reform of European clinical trials
Smaller companies suffering from a bureaucratic burden..(more)

 Financial weak spots still plague NHS
PCTs continue to struggle with their debts..(more)

 AZ website supports mental health switching
Company aims to promote shared decision making in mental health..(more)

 Latest news from Datamonitor
Product roundup in metabolic diseases, cancer and HIV..(more)

 Pfizer abandons Exubera
Poor sales force company to cut its losses..(more)

 Pharma consultants on shortlist to help PCTs improve services
Approved list intended to reduce unnecessary costs..(more)

 New products behind Lilly growth
But company still reliant on older blockbuster Zyprexa ..(more)

 Novartis changes pharma management after weak third quarter
Jim Jimenez to head up pharma division..(more)

 Genzyme expands UK presence
New facilities reflect continued UK growth..(more)

 Latest news from Datamonitor
Clinical roundup in cancer, asthma and vaccines..(more)

 Underperforming NHS trusts threatened with takeover
Four worst performers face meeting with NHS chief executive..(more)

 NHS spending growth slows
Spending review includes funds for proposed Darzi reforms..(more)

 Eucreas a step nearer European approval
Combination pill is latest multiple agent diabetes treatment..(more)

 Efficiency drive has saved NHS millions, say ministers
Major savings from mass change from branded to generics ..(more)

 Pfizer to set up separate biotech arm
New San Francisco centre represents new R&D strategy..(more)

 Gates Foundation invests $100m in unorthodox research
Grants offer funding hopes for tackling major disease in the developing world ..(more)

 Wyeth names new chief executive
Bernard Poussot to take top job after 22 years at the company..(more)

 Latest news from Datamonitor
Product roundup in asthma, menopause, depression, obesity and cancer..(more)

 £100m boost for NHS innovation
New council set up in the wake of Darzi's report..(more)

 Wyeth buys Scottish biotech firm
Acquisition of Haptogen brings with it unique immune system technology..(more)

 GSK appoints Witty to top job
Witty beats two other candidates to become CEO..(more)

 Roche cuts Tarceva price while NICE deliberate
Price-cut is attempt by company to avoid NICE blight ..(more)

 FDA rejects painkiller Prexige
Drug not approved after concerns of serious liver-related side-effects ..(more)

 Eisai to appeal against Alzheimer's court ruling
NICE to face challenge on procedural fairness and cost-effectiveness model..(more)

 BMA resists plans for London polyclinics
Concerns that money will be spent with little benefit to patients..(more)

 mXm launches event ROI Monitor
New tool will measure value of communication activities..(more)

 Regulators and pharma to join forces on drug safety monitoring
New consortium will pool health industry data and expertise..(more)

 Leukaemia drug enters phase III studies in MS
Alemtuzumab shows advantages over beta interferon in phase II trials..(more)

 Society launches MS awareness campaign
Spencer du Bois adds MS Society to its list of health charity clients..(more)

 Latest news from Datamonitor
Product roundup in infections, hypertension, cancer and weight control..(more)

Are you a Pharmafocus subscriber?

Subscribe Now 

Visit our sister sites: 

InPharm.com 

Pharmafile.com 

Pharmafocus.com © 2006 Pharmafile Ltd.